3 Followers on Owler
OverviewCompetitorsNews & Insights

Insentia Competitors or Alternatives

Insentia's top competitors include Trusted Tablets, High Times and Ubiquiti.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • CEO

    CEO RATING

    EMPLOYEES

  • FUNDING

    REVENUE

  • CEO

    CEO RATING

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Insentia's company profile

Rivo Radanielina

CEO

68/100
1 - 25
$0
$100K - 5M

  • Rivo Radanielina

    CEO

    68/100
    1 - 25
  • $0
    $100K - 5M

  • Rivo Radanielina

    CEO

    68/100
  • 1 - 25
    $0
  • $100K - 5M

  • Rivo Radanielina

    CEO

  • 68/100
  • 1 - 25
  • $0
  • $100K - 5M
View ProfileView
1
Insentia's Competitor - Trusted Tablets logo

CEO

- -
25 - 100
- -
$5M - 25M

  • CEO

    - -
    25 - 100
  • - -
    $5M - 25M

  • CEO

    - -
  • 25 - 100
    - -
  • $5M - 25M

  • CEO

  • - -
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
2
Insentia's Competitor - High Times logo

Peter Horvath

CEO

55/100
25 - 100
$10M
$5M - 25M

  • Peter Horvath

    CEO

    55/100
    25 - 100
  • $10M
    $5M - 25M

  • Peter Horvath

    CEO

    55/100
  • 25 - 100
    $10M
  • $5M - 25M

  • Peter Horvath

    CEO

  • 55/100
  • 25 - 100
  • $10M
  • $5M - 25M
View ProfileView
3
Insentia's Competitor - Ubiquiti logo

Robert J. Pera

Chairman & CEO

46/100
1,380
$105.6M
$1.8B

  • Robert J. Pera

    Chairman & CEO

    46/100
    1,380
  • $105.6M
    $1.8B

  • Robert J. Pera

    Chairman & CEO

    46/100
  • 1,380
    $105.6M
  • $1.8B

  • Robert J. Pera

    Chairman & CEO

  • 46/100
  • 1,380
  • $105.6M
  • $1.8B
View ProfileView
4
Insentia's Competitor - AltMed logo

John Tipton

CEO

84/100
250 - 500
$35.4M
$25M - 100M

  • John Tipton

    CEO

    84/100
    250 - 500
  • $35.4M
    $25M - 100M

  • John Tipton

    CEO

    84/100
  • 250 - 500
    $35.4M
  • $25M - 100M

  • John Tipton

    CEO

  • 84/100
  • 250 - 500
  • $35.4M
  • $25M - 100M
View ProfileView
5
Insentia's Competitor - Lilly logo

David A. Ricks

Chairman & CEO

92/100
39,000
- -
$28.5B

  • David A. Ricks

    Chairman & CEO

    92/100
    39,000
  • - -
    $28.5B

  • David A. Ricks

    Chairman & CEO

    92/100
  • 39,000
    - -
  • $28.5B

  • David A. Ricks

    Chairman & CEO

  • 92/100
  • 39,000
  • - -
  • $28.5B
View ProfileView
Insentia's top 15 competitors are Trusted Tablets, High Times, Ubiquiti, Vicore Pharma, AltMed, Lilly, Ability Pharma, Abbott, Cipla, BMS, Trustpilot, Lilly Oncology, YGvtc, Cambium Networks and 420 Magazine. Together they have raised over 464.1M between their estimated 217.4K employees. Insentia's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 7.7B. Insentia has 22 employees and is ranked 13th among it's top 10 competitors. The top 10 competitors average 13,587.

Trusted Tablets is one of Insentia's top rivals. Trusted Tablets was founded in Larnaca, Larnarca District} in 2007. Trusted Tablets is in the industry. Compared to Insentia, Trusted Tablets generates $1.2M more revenue.

High Times is Insentia's #2 competitor. High Times was founded in 1974, and is headquartered in Los Angeles, California. High Times competes in the industry. High Times generates $10.3M more revenue vs. Insentia.

Ubiquiti is a top competitor of Insentia. Ubiquiti's headquarters is in New York, New York, and was founded in 2003. Ubiquiti operates in the industry. Ubiquiti generates 40,653% of Insentia's revenue.

Looking for similar companies to Insentia?

Trending News for Insentia and Insentia's Competitors

March 29, 2023Pharamceutical Technology
The collaboration aims to discover and develop new medicines using Evotec's modality-agnostic precision medicine platforms....
March 29, 2023PMLiVE
The biologics manufacturing site is expected to create more than 300 highly skilled jobs...
Today 8:17 AMNasdaq
British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of its long-acting HIV preventive medici...
Today 1:30 PMMarketScreener
(marketscreener.com) Ruggedized XE3-4TN access point provides high-performance Wi-Fi infrastructure for applications including video surveillance, high...
March 29, 2023BioSpace
Abbott will announce its first-quarter 2023 financial results on Wednesday, April 19, 2023, before the market opens....
Today 12:00 PMBioPharma-Reporter
The US biotech CytomX has lost a collaboration partner as AbbVie pulled out of a collaboration developing an antibody-drug conjugate (ADC) for the trea...
Today 7:20 AMBusiness Recorder
BENGALURU: Johnson & Johnson said it will discontinue the late-stage study of its experimental respiratory syncytial virus (RSV) adult vaccine, weeks a...
Today 1:07 PMProactive Investors
GSK PLC (LSE:GSK, NYSE:GSK) has entered into agreements with three firms to produce affordable generic versions of its long-lasting HIV prevention drug...
Today 1:31 PMBioSpace
Merck, known as MSD outside of the United States and Canada, will hold its first-quarter 2023 sales and earnings conference call with institutional inv...
Today 2:44 PMBloomberg Law
Pfizer Inc.'s deal-making goal is close to complete with its planned acquisition of cancer-drug maker Seagen Inc., according to an attorney who worked ...

Frequently Asked Questions about Insentia

  1. Who are Insentia's top competitors?

    Insentia's top 3 competitors are Trusted Tablets, High Times, Ubiquiti.

  2. Who is similar to Insentia?

    Trusted Tablets is the most similar to Insentia. High Times and Ubiquiti are also similar to Insentia.

  1. Are Insentia and Trusted Tablets competitors?

    Yes, Trusted Tablets is one of Insentia’s top competitors.